The other two forms are hydroxocobalamin and cyanocobalamin
Activity observed in animal models or small early studies does not automatically translate into predictable, beneficial effects in human patients, and none of this constitutes a basis for DSIP dosage recommendations
Structure Sequence: Glycyl-L-Histidyl-L-Lysine Copper (GHK-Cu) Molecular Formula: C14H24N6O4Cu Molecular Weight: 403.92 g/mol PubChem CID: 3081431 Citations for GHK-Cu Collagen Synthesis & Skin Rejuvenation Pickart, L., et al
The study discussed here was relatively small, involving only 17 patients, and more extensive clinical trials are needed to fully understand: Long-term safety profile Optimal dosing protocols Patient selection criteria Potential side effects Interactions with other treatments Additionally, patients should be aware that BPC-157 is not yet FDA-approved for human use, and treatment is typically offered on a research or compassionate use basis by qualified practitioners
In some embodiments, the otic formulation or composition comprises between about 0.01% to about 2% by weight of the silicon dioxide
